Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis

Sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors have complementary mode of action. For the meta-analysis comparing the efficacy and safety between SGLT2 inhibitor plus DPP4 inhibitor (SGLT2i/DPP4i) and placebo plus DPP4 inhibitor (PCB/DPP4i) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Se Hee, Yoon, Jeong-Hwa, Moon, Sun Joon, Hahn, Seokyung, Cho, Young Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849757/
https://www.ncbi.nlm.nih.gov/pubmed/29535389
http://dx.doi.org/10.1038/s41598-018-22658-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849757/
https://www.ncbi.nlm.nih.gov/pubmed/29535389
http://dx.doi.org/10.1038/s41598-018-22658-2

Ejemplares similares